Identify Cardiac Risk Prior to Therapy Prescription
AliveCor’s FDA-cleared ECG devices help remove barriers to prescribing, accelerate time to therapy, and improve adherence—all while strengthening cardiac safety.
Lower patient costs by reducing expenses related to specialist visits for preliminary ECGs, and empower timely, informed decisions that lead to more appropriate patient care.
Trusted by doctors, preferred by patients
Start therapy sooner, no referral delays
Support safer prescribing with real-time cardiac data
Let’s Connect